Evidence map›Paper›PMID 20562305›Full record

ArticleJournal of bacteriology2010

Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.

Stefan Czurda, Wolfgang Jechlinger, Renate Rosengarten, Rohini Chopra-Dewasthaly

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.FEMS immunology and medical microbiology · 2012
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stefan CzurdaInstitute of Bacteriology, Mycology and Hygiene (IBMH), Department of Pathobiology, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna, Austria.
Wolfgang Jechlinger
Renate Rosengarten
Rohini Chopra-Dewasthaly
University of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund FWF P 21796
6 · The paper itself

Abstract

Surface antigen variation in Mycoplasma agalactiae, the etiologic agent of contagious agalactia in sheep and goats, is governed by site-specific recombination within the vpma multigene locus encoding the Vpma family of variable surface lipoproteins. This high-frequency Vpma phase switching was previously shown to be mediated by a Xer1 recombinase encoded adjacent to the vpma locus. In this study, it was demonstrated in Escherichia coli that the Xer1 recombinase is responsible for catalyzing vpma gene inversions between recombination sites (RS) located in the 5'-untranslated region (UTR) in all six vpma genes, causing cleavage and strand exchange within a 21-bp conserved region that serves as a recognition sequence. It was further shown that the outcome of the site-specific recombination event depends on the orientation of the two vpma RS, as direct or inverted repeats. While recombination between inverted vpma RS led to inversions, recombination between direct repeat vpma RS led to excisions. Using a newly developed excision assay based on the lacZ reporter system, we were able to successfully demonstrate under native conditions that such Xer1-mediated excisions can indeed also occur in the M. agalactiae type strain PG2, whereas they were not observed in the control xer1-disrupted VpmaY phase-locked mutant (PLMY), which lacks Xer1 recombinase. Unless there are specific regulatory mechanisms preventing such excisions, this might be the cost that the pathogen has to render at the population level for maintaining this high-frequency phase variation machinery.

Indexed as

LipoproteinsMembrane ProteinsMutagenesis, Site-DirectedAnimalsAntigenic VariationBacterial ProteinsBase SequenceChromosome InversionDNA, BacterialGene Expression Regulation, BacterialMolecular Sequence DataMultigene FamilyMycoplasma agalactiaeRecombinasesRecombination, GeneticBacterial ProteinsDNA, BacterialLipoproteinsMembrane ProteinsRecombinases

Identifiers

PMID20562305
PMCPMC2937384
OpenAlexW1976027706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.